MRC and MND Association award £3.9m to KCL and UCL for ALS/FTD research
Researchers aim to explore and investigate axonal dysfunction in neurodegeneration
Read Moreby Jen Brogan | Aug 7, 2024 | News | 0
Researchers aim to explore and investigate axonal dysfunction in neurodegeneration
Read Moreby Jen Brogan | Jul 25, 2024 | News | 0
The research will help to better understand how this pathway is coordinated in the cell
Read Moreby Jen Brogan | Jul 12, 2024 | News | 0
The serious, rare condition is responsible for up to 7% of all neonatal deaths globally
Read Moreby Jen Brogan | May 31, 2024 | News | 0
The projects will focus on a range of research areas, including Down’s syndrome and ALS
Read Moreby Jen Brogan | May 28, 2024 | News | 0
The MRC BRC and the MDU will use the funding and cutting-edge research to improve public health until March 2029
Read Moreby Jen Brogan | May 23, 2024 | News | 0
The partnership will provide six MRC clinical fellows with industry placement opportunities
Read Moreby Jen Brogan | Apr 23, 2024 | News | 0
Severe acute malnutrition is responsible for nearly half of all child deaths globally and affects 17 million children annually
Read Moreby Jen Brogan | Mar 26, 2024 | News | 0
According to the World Health Organization, TB is responsible for over one million annual deaths
Read Moreby Jen Brogan | Feb 22, 2024 | News | 0
The trial is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent
Read Moreby Jen Brogan | Jan 31, 2024 | News | 0
The institute is one of two UK laboratories wholly funded by the MRC
Read Moreby Jen Brogan | Nov 29, 2023 | News | 0
The new state-of-the-art facility is set to be operational in early 2024
Read Moreby Jen Brogan | Oct 6, 2023 | News | 0
NPIP will transform medical research and provide better outcomes for patients
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
